Erratum: Comparative analysis of antigen-targeting sequences used in DNA vaccines (Mol Biotechnol (DOI: 10.1007/s12033-009-9229-x);Comparative analysis of antigen-targeting sequences used in DNA vaccines

Molecular Biotechnology

Volumn 44, Issue 3, 2010, Pages 204-212

  Carvalho, Joana A ^a   Azzoni, Adriano R ^a   Prazeres, Duarte M F ^a   Monteiro, Gabriel A ^a  

^a INSTITUTO SUPERIOR TÉCNICO   (Portugal)

Author keywords

Antigen processing pathways; Antigen targeting; DNA vaccines; Plasmid DNA; Vector design

Indexed keywords

ACTIVATION ANALYSIS; ANTIGENS; CELL MEMBRANES; CYTOLOGY; DNA; FLUORESCENCE; MOLECULAR BIOLOGY; NUCLEIC ACIDS; PHYSIOLOGY; PROTEINS; TRANSCRIPTION; VACCINES;

ANTIGEN PROCESSING; ANTIGEN-TARGETING; DNA VACCINE; PLASMID DNA; VECTOR DESIGN;

DNA SEQUENCES;

DNA VACCINE; HYBRID PROTEIN; INVARIANT SURFACE GLYCOPROTEIN GREEN FLUORESCENT PROTEIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MESSENGER RNA; PLASMID VECTOR; PROTOZOAL PROTEIN; TRANSSIALIDASE GREEN FLUORESCENT PROTEIN; TRYPANOSOMA VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CHO CELL; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DESIGN; ENDOPLASMIC RETICULUM; FLOW CYTOMETRY; GENE CONSTRUCT; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; REPORTER GENE; RNA TRANSCRIPTION; TRYPANOSOMA BRUCEI;

ADENOVIRIDAE; TRYPANOSOMA BRUCEI;

EID: 77649237006     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12033-010-9327-9     Document Type: Erratum

References (49)

1. AM Bodles-Brakhop R Draghia-Akli 2008 DNA vaccination and gene therapy: Optimization and delivery for cancer therapy Expert Review of Vaccines 7 7 1085 1101 10.1586/14760584.7.7.1085 1:CAS:528:DC%2BD1cXhtVOiur%2FL
2. Y Okura A Miyakoshi K Kohyama IK Park M Staufenbiel Y Matsumoto 2006 Nonviral Abeta DNA vaccine therapy against Alzheimer's disease: Long-term effects and safety Proceedings of the National Academy of Sciences of the United States of America 103 25 9619 9624 10.1073/pnas.0600966103 1:CAS:528: DC%2BD28XmsVOnsLc%3D (Pubitemid 43955874)
3. G Li Z Liu N Zhong B Liao Y Xiong 2006 Therapeutic effects of DNA vaccine on allergen-induced allergic airway inflammation in mouse model Cellular and Molecular Immunology 3 5 379 384 1:CAS:528:DC%2BD28XhtlensLrK
4. DJ Laddy DB Weiner 2006 From plasmids to protection: a review of DNA vaccines against infectious diseases International Reviews of Immunology 25 3-4 99 123 10.1080/08830180600785827 1:CAS:528:DC%2BD28XotVekt7g%3D (Pubitemid 44034576)
5. P Chikhlikar LB de Arruda M Maciel, et al. 2006 DNA encoding an HIV-1 Gag/human lysosome-associated membrane protein-1 chimera elicits a broad cellular and humoral immune response in Rhesus macaques PLoS ONE 1 e135 10.1371/journal.pone.0000135
6. DF Hoft CS Eickhoff OK Giddings JRC Vasconcelos MM Rodrigues 2007 Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming Journal of Immunology 179 10 6889 6900 1:CAS:528:DC%2BD2sXht1Crs7%2FK
7. JA Carvalho DM Prazeres GA Monteiro 2009 Bringing DNA vaccines closer to commercial use IDrugs 12 10 642 647
8. DM Klinman G Yamshchikov Y Ishigatsubo 1997 Contribution of CpG motifs to the immunogenicity of DNA vaccines Journal of Immunology 158 8 3635 3639 1:CAS:528:DyaK2sXisFCitb4%3D
9. YK Cheung SC-S Cheng FW-Y Sin Y Xie 2004 Plasmid encoding papillomavirus Type 16 (HPV16) DNA constructed with codon optimization improved the immunogenicity against HPV infection Vaccine 23 5 629 638 10.1016/j.vaccine. 2004.07.010 1:CAS:528:DC%2BD2cXpslGjtrc%3D (Pubitemid 39473192)
10. P Moreau R Hen B Wasylyk R Everett MP Gaub P Chambon 1981 The SV40 72 base repair repeat has a striking effect on gene expression both in SV40 and other chimeric recombinants Nucleic Acids Research 9 22 6047 6068 10.1093/nar/9.22.6047 1:CAS:528:DyaL38Xks1ymtg%3D%3D
11. DH Barouch Yang Zy Kong Wp, et al. 2005 A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates Journal of Virology 79 14 8828 8834 10.1128/JVI.79.14.8828-8834.2005 1:CAS:528:DC%2BD2MXmtFOjs70%3D (Pubitemid 40934793)
12. JJ Kim KA Simbiri JI Sin, et al. 1999 Cytokine molecular adjuvants modulate immune responses induced by DNA vaccine constructs for HIV-1 and SIV Journal of Interferon and Cytokine Research 19 1 77 84 10.1089/107999099314441 1:CAS:528:DyaK1MXhtFalt7Y%3D (Pubitemid 29070235)
13. R Xu S Megati V Roopchand, et al. 2008 Comparative ability of various plasmid-based cytokines and chemokines to adjuvant the activity of HIV plasmid DNA vaccines Vaccine 26 37 4819 4829 10.1016/j.vaccine.2008.06.103 1:CAS:528:DC%2BD1cXhtVagsLrL
14. DH Barouch S Santra JE Schmitz, et al. 2000 Control of viremia and prevention of clinical AIDS in Rhesus monkeys by cytokine-augmented DNA vaccination Science 290 5491 486 492 10.1126/science.290.5491.486 1:CAS:528:DC%2BD3cXnsFKjtbY%3D (Pubitemid 30808933)
15. D Wang ME Christopher LP Nagata, et al. 2004 Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses Journal of Clinical Virology 31 Supplement 1 99 106 10.1016/j.jcv.2004.09.013 1:CAS:528: DC%2BD2MXitFGjtbo%3D (Pubitemid 39574715)
16. GR Otten M Schaefer B Doe, et al. 2005 Enhanced potency of plasmid DNA microparticle human immunodeficiency virus vaccines in rhesus macaques by using a priming-boosting regimen with recombinant proteins Journal of Virology 79 13 8189 8200 10.1128/JVI.79.13.8189-8200.2005 1:CAS:528:DC%2BD2MXlslGjtb0%3D (Pubitemid 40853522)
17. G Minigo A Scholzen CK Tang, et al. 2007 Poly-l-lysine-coated nanoparticles: A potent delivery system to enhance DNA vaccine efficacy Vaccine 25 7 1316 1327 10.1016/j.vaccine.2006.09.086 1:CAS:528:DC%2BD2sXisVGjsg%3D%3D (Pubitemid 46027334)
18. JS Boyle C Koniaras AM Lew 1997 Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: Cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization International Immunology 9 12 1897 1906 10.1093/intimm/9.12.1897 1:CAS:528:DyaK1cXktVWjtA%3D%3D (Pubitemid 28005827)
19. W Xu Y Chu R Zhang H Xu Y Wang S Xiong 2005 Endoplasmic reticulum targeting sequence enhances HBV-specific cytotoxic T lymphocytes induced by a CTL epitope-based DNA vaccine Virology 334 2 255 263 10.1016/j.virol.2005.01.040 1:CAS:528:DC%2BD2MXisVCltbo%3D (Pubitemid 40386959)
20. LB Arruda D Sim PR Chikhlikar, et al. 2006 Dendritic cell-lysosomal- associated membrane protein (LAMP) and LAMP-1-HIV-1 gag chimeras have distinct cellular trafficking pathways and prime T and B cell responses to a diverse repertoire of epitopes Journal of Immunology 177 4 2265 2275 1:CAS:528:DC%2BD28Xns1Khtbs%3D
21. AM Henriques M Fevereiro DMF Prazeres GA Monteiro 2007 Development of a candidate DNA vaccine against Maedi-Visna virus Veterinary Immunology and Immunopathology 119 3-4 222 232 10.1016/j.vetimm.2007.05.004 1:CAS:528:DC%2BD2sXhtVWht7fM (Pubitemid 47368672)
22. P Overath M Chaudhri D Steverding K Ziegelbauer 1994 Invariant surface proteins in bloodstream forms of Trypanosoma brucei Parasitology Today 10 2 53 58 10.1016/0169-4758(94)90393-X 1:CAS:528:DyaK2cXktlSmt7o%3D (Pubitemid 24052917)
23. MS Silva DMF Prazeres A Lança J Atouguia GA Monteiro 2009 Trans-sialidase from Trypanosoma brucei as a potential target for DNA vaccine development against African trypanosomiasis Parasitology Research 105 5 53 58 10.1007/s00436-009-1542-6
24. JT Qiu B Liu C Tian GN Pavlakis XF Yu 2000 Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target gag antigen to the secretory pathway Journal of Virology 74 13 5997 6005 10.1128/JVI.74.13.5997-6005.2000 1:CAS:528:DC%2BD3cXkt1eiurw%3D (Pubitemid 30412969)
25. AL Ruff FG Guarnieri K Staveley-O'Carroll RF Siliciano JT August 1997 The enhanced immune response to the HIV gp160/LAMP chimeric gene product targeted to the lysosome membrane protein trafficking pathway Journal of Biological Chemistry 272 13 8671 8678 10.1074/jbc.272.13.8671 1:CAS:528:DyaK2sXitF2hsLs%3D (Pubitemid 27147834)
26. H Persson H Jornvall J Zabielski 1980 Multiple mRNA species for the precursor to an adenovirus-encoded glycoprotein: Identification and structure of the signal sequence Proceedings of the National Academy of Sciences of the United States of America 77 11 6349 6353 10.1073/pnas.77.11.6349 1:CAS:528:DyaL3MXmtVShuw%3D%3D (Pubitemid 11219142)
27. AR Azzoni SC Ribeiro GA Monteiro DM Prazeres 2007 The impact of polyadenylation signals on plasmid nuclease-resistance and transgene expression Journal of Gene Medicine 9 5 392 402 10.1002/jgm.1031 1:CAS:528: DC%2BD2sXntlOhtrw%3D (Pubitemid 46796585)
28. SC Ribeiro GA Monteiro DM Prazeres 2004 The role of polyadenylation signal secondary structures on the resistance of plasmid vectors to nucleases Journal of Gene Medicine 6 5 565 573 10.1002/jgm.536 1:CAS:528: DC%2BD2cXlt1Cmtr8%3D (Pubitemid 40228072)
29. SA Thomson SR Burrows IS Misko DJ Moss B Eá H Coupar R Khanna 1998 Targeting a polyepitope protein incorporating multiple class II-restricted viral epitopes to the secretory/endocytic pathway facilitates immune recognition by CD4+ cytotoxic T lymphocytes: A novel approach to vaccine design Journal of Virology 72 3 2246 2252 1:CAS:528:DyaK1cXhtFehsrY%3D
30. RG Werner W Noe K Kopp M Schluter 1998 Appropriate mammalian expression systems for biopharmaceuticals Arzneimittelforschung 48 8 870 880 1:CAS:528:DyaK1cXlsF2js74%3D
31. E Carapuca AR Azzoni DM Prazeres GA Monteiro FJ Mergulhao 2007 Time-course determination of plasmid content in eukaryotic and prokaryotic cells using real-time PCR Molecular Biotechnology 37 2 120 126 10.1007/s12033-007- 0007-3 1:CAS:528:DC%2BD2sXhtFKmtLrK (Pubitemid 350135888)
32. NM Seibel J Eljouni MM Nalaskowski W Hampe 2007 Nuclear localization of enhanced green fluorescent protein homomultimers Analytical Biochemistry 368 1 95 99 10.1016/j.ab.2007.05.025 1:CAS:528:DC%2BD2sXotVWltr4%3D (Pubitemid 47058434)
33. E Vázquez N Ferrer-Miralles A Villaverde 2008 Peptide-assisted traffic engineering for nonviral gene therapy Drug Discovery Today 13 23-24 1067 1074 10.1016/j.drudis.2008.08.008
34. D Hoekstra J Rejman L Wasungu F Shi I Zuhorn 2007 Gene delivery by cationic lipids: In and out of an endosome Biochemical Society Transactions 35 Pt 1 68 71 1:CAS:528:DC%2BD2sXit1Oktrg%3D (Pubitemid 46271811)
35. D Lechardeur AS Verkman GL Lukacs 2005 Intracellular routing of plasmid DNA during non-viral gene transfer Advanced Drug Delivery Reviews 57 5 755 767 10.1016/j.addr.2004.12.008 1:CAS:528:DC%2BD2MXitFertbk%3D (Pubitemid 40332601)
36. 2+-sensitive cytosolic nucleases prevent efficient delivery to the nucleus of injected plasmids Journal of Gene Medicine 3 2 153 164 10.1002/jgm.160 1:STN:280:DC%2BD3MvkslGktw%3D%3D (Pubitemid 33685442)
37. R Tachibana H Harashima N Ide, et al. 2002 Quantitative analysis of correlation between number of nuclear plasmids and gene expression activity after transfection with cationic liposomes Pharmaceutical Research 19 4 377 381 10.1023/A:1015162722295 1:CAS:528:DC%2BD38XjvFaqu7c%3D (Pubitemid 34408932)
38. J Vacik BS Dean WE Zimmer DA Dean 1999 Cell-specific nuclear import of plasmid DNA Gene Therapy 6 6 1006 1014 10.1038/sj.gt.3300924 1:CAS:528:DyaK1MXjvVSit7k%3D (Pubitemid 29295205)
39. DA Dean 1997 Import of plasmid DNA into the nucleus is sequence specific Experimental Cell Research 230 2 293 302 10.1006/excr.1996.3427 1:CAS:528:DyaK2sXhtVShtbY%3D (Pubitemid 27190649)
40. M Ruponen S Arkko A Urtti M Reinisalo VP Ranta 2009 Intracellular DNA release and elimination correlate poorly with transgene expression after non-viral transfection Journal of Controlled Release 136 3 226 231 10.1016/j.jconrel.2009.02.012 1:CAS:528:DC%2BD1MXmsFOhurY%3D
41. CM Roth S Sundaram 2004 Engineering synthetic vectors for improved DNA delivery: Insights from intracellular pathways Annual Review of Biomedical Engineering 6 1 397 426 10.1146/annurev.bioeng.6.040803.140203 1:CAS:528:DC%2BD2cXns1yitbk%3D (Pubitemid 39209504)
42. A Krogh Br Larsson G von Heijne ELL Sonnhammer 2001 Predicting transmembrane protein topology with a hidden markov model: Application to complete genomes Journal of Molecular Biology 305 3 567 580 10.1006/jmbi.2000. 4315 1:CAS:528:DC%2BD3MXisFCguw%3D%3D (Pubitemid 33032862)
43. N Rocha J Neefjes 2008 MHC class II molecules on the move for successful antigen presentation EMBO Journal 27 1 1 5 10.1038/sj.emboj.7601945 1:CAS:528:DC%2BD1cXksVKjtw%3D%3D
44. ETA Marques Jr P Chikhlikar LB De Arruda, et al. 2003 HIV-1 p55Gag encoded in the lysosome-associated membrane protein-1 as a DNA plasmid vaccine chimera is highly expressed, traffics to the major histocompatibility class II compartment, and elicits enhanced immune responses Journal of Biological Chemistry 278 39 37926 37936 10.1074/jbc.M303336200 1:CAS:528: DC%2BD3sXnsV2ltb0%3D (Pubitemid 37175323)
45. HA Andersson MA Barry 2004 Maximizing antigen targeting to the proteasome for gene-based vaccines Molecular Therapy 10 3 432 446 10.1016/j.ymthe.2004.05. 035 1:CAS:528:DC%2BD2cXntVOjsrk%3D (Pubitemid 39186107)
46. AT Kamath CG Feng M Macdonald H Briscoe WJ Britton 1999 Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis Infection and Immunity 67 4 1702 1707 1:CAS:528:DyaK1MXitFCrs7w%3D
47. SJ Kim D Suh SE Park, et al. 2003 Enhanced immunogenicity of DNA fusion vaccine encoding secreted hepatitis B surface antigen and chemokine RANTES Virology 314 1 84 91 10.1016/S0042-6822(03)00417-3 1:CAS:528: DC%2BD3sXnsVWqsr0%3D (Pubitemid 37153301)
48. M Suk Kim JI Sin 2005 Both antigen optimization and lysosomal targeting are required for enhanced anti-tumour protective immunity in a human papillomavirus E7-expressing animal tumour model Immunology 116 2 255 266 10.1111/j.1365-2567.2005.02219.x (Pubitemid 41368667)
49. M Sherritt L Cooper DJ Moss N Kienzle J Altman R Khanna 2001 Immunization with tumor-associated epitopes fused to an endoplasmic reticulum translocation signal sequence affords protection against tumors with down-regulated expression of MHC and peptide transporters International Immunology 13 3 265 271 10.1093/intimm/13.3.265 1:CAS:528:DC%2BD3MXhvVOhtr4%3D